-
Je něco špatně v tomto záznamu ?
Advances in protease inhibition-based chemotherapy: A decade of insights from Malaria research
D. Sojka, P. Šnebergerová
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, přehledy
- MeSH
- antimalarika * farmakologie terapeutické užití MeSH
- inhibitory proteas * terapeutické užití MeSH
- lidé MeSH
- malárie farmakoterapie MeSH
- Plasmodium falciparum * enzymologie účinky léků genetika MeSH
- proteasy metabolismus genetika MeSH
- tropická malárie farmakoterapie parazitologie MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Over the last decade, research on the most studied parasite, Plasmodium falciparum, has disclosed significant findings in protease research. Detailed descriptions of the individual roles of protease isoenzymes from various protease classes encoded by the parasite genome have been elucidated, along with their functional and biochemical characterizations. These insights have enabled the development of innovative chemotherapy using low molecular weight inhibitors targeting specific molecular sites. Progress has been made in understanding the proteolytic cascade associated with the apical complex, particularly the roles of aspartyl proteases plasmepsins IX and X as master regulators. Additionally, advancements in direct and alternative methods of proteasome inhibition and expression regulation have been achieved. Research on digestive/food vacuole-associated proteases, with a focus on essential metalloproteases, has also seen significant developments. The rise of extensive genomic datasets and functional genomic tools for other parasitic organisms now allows these approaches to be applied to the study and treatment of other, less known parasitic diseases, aiming to uncover specific biological mechanisms and develop innovative, less toxic chemotherapies.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25004191
- 003
- CZ-PrNML
- 005
- 20250206110005.0
- 007
- ta
- 008
- 250121e20240830enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/bs.apar.2024.07.001 $2 doi
- 035 __
- $a (PubMed)39448191
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Sojka, Daniel $u Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Ceske Budejovice, Czech Republic. Electronic address: sojkadan@gmail.com
- 245 10
- $a Advances in protease inhibition-based chemotherapy: A decade of insights from Malaria research / $c D. Sojka, P. Šnebergerová
- 520 9_
- $a Over the last decade, research on the most studied parasite, Plasmodium falciparum, has disclosed significant findings in protease research. Detailed descriptions of the individual roles of protease isoenzymes from various protease classes encoded by the parasite genome have been elucidated, along with their functional and biochemical characterizations. These insights have enabled the development of innovative chemotherapy using low molecular weight inhibitors targeting specific molecular sites. Progress has been made in understanding the proteolytic cascade associated with the apical complex, particularly the roles of aspartyl proteases plasmepsins IX and X as master regulators. Additionally, advancements in direct and alternative methods of proteasome inhibition and expression regulation have been achieved. Research on digestive/food vacuole-associated proteases, with a focus on essential metalloproteases, has also seen significant developments. The rise of extensive genomic datasets and functional genomic tools for other parasitic organisms now allows these approaches to be applied to the study and treatment of other, less known parasitic diseases, aiming to uncover specific biological mechanisms and develop innovative, less toxic chemotherapies.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a Plasmodium falciparum $x enzymologie $x účinky léků $x genetika $7 D010963
- 650 12
- $a inhibitory proteas $x terapeutické užití $7 D011480
- 650 12
- $a antimalarika $x farmakologie $x terapeutické užití $7 D000962
- 650 _2
- $a proteasy $x metabolismus $x genetika $7 D010447
- 650 _2
- $a tropická malárie $x farmakoterapie $x parazitologie $7 D016778
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a malárie $x farmakoterapie $7 D008288
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Šnebergerová, Pavla $u Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Ceske Budejovice, Czech Republic; Faculty of Science, University of South Bohemia, Ceske Budejovice, Czech Republic
- 773 0_
- $w MED00000166 $t Advances in parasitology $x 2163-6079 $g Roč. 126 (20240830), s. 205-227
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39448191 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250121 $b ABA008
- 991 __
- $a 20250206110001 $b ABA008
- 999 __
- $a ok $b bmc $g 2263742 $s 1240198
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 126 $c - $d 205-227 $e 20240830 $i 2163-6079 $m Advances in parasitology $n Adv Parasitol $x MED00000166
- LZP __
- $a Pubmed-20250121